- 米国企業
- Anebulo Pharmaceuticals, Inc.
Anebulo Pharmaceuticals, Inc.ANEB
時価総額
$5420万
PER
2021年 6月30日 | 2022年 6月30日 | 2023年 6月30日 | |
Cash | 20 | 15 | 11 |
Prepaid expenses | - | 1 | 422,748 |
Total assets | 22 | 16 | 12 |
Accounts payable | 110,048 | 380,828 | 534,545 |
Accrued expenses | 131,585 | 131,703 | 534,256 |
Total liabilities | 241,633 | 512,531 | 1 |
Common stock, $0.001 par value; 40,000,000 shares authorized; 25,633,217 and 23,344,567 shares issued and outstanding at June 30, 2023 and 2022, respectively | 23,345 | 23,345 | 25,634 |
Additional paid-in capital | 60 | 61 | 68 |
Accumulated deficit | -38,644,084 | -45,469,703 | -57,202,041 |
Total stockholders’ equity | 21 | 15 | 11 |
Total liabilities and stockholders’ equity | 22 | 16 | 12 |